MATRIX METALLOPROTEINASE INHIBITOR FOR THE TREATMENT OF ALS

$961,150FY2022Defense Health AgencyDOD

Aquilus Pharmaceuticals, Inc., Winchester MA

Investigators

View source on USAspending →